REFERENCES
1. Singh G, Daus G, Allender M, et al. Social Determinants of Health in
the United States: Addressing Major Health Inequality Trends for the
Nation, 1935-2016. Int J MCH AIDS . 2017;6(2):139-164.
doi:10.21106/ijma.236
2. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting
Racial and Ethnic Disparities in Health Care (with CD) .; 2003.
doi:10.17226/12875
3. Marmot M, Friel S, Bell R, Houweling TA, Taylor S. Closing the gap in
a generation: health equity through action on the social determinants of
health. Lancet . 2008;372(9650):1661-1669.
doi:10.1016/S0140-6736(08)61690-6
4. Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC.
Understanding and addressing social determinants to advance cancer
health equity in the United States: A blueprint for practice, research,
and policy. CA Cancer J Clin . 2020;70(1):31-46.
doi:10.3322/caac.21586
5. Sayani A. Health equity in national cancer control plans: An analysis
of the ontario cancer plan. Int J Heal Policy Manag .
2019;8(9):550-556. doi:10.15171/ijhpm.2019.40
6. Temkin SM, Rimel BJ, Bruegl AS, Gunderson CC, Beavis AL, Doll KM. A
contemporary framework of health equity applied to gynecologic cancer
care: A Society of Gynecologic Oncology evidenced-based review.Gynecol Oncol . 2018;149(1):70-77. doi:10.1016/j.ygyno.2017.11.013
7. Ward E, Jemal A, Cokkinides V, et al. Cancer Disparities by
Race/Ethnicity and Socioeconomic Status. CA Cancer J Clin .
2004;54(2):78-93. doi:10.3322/canjclin.54.2.78
8. Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of
socioeconomic status on stage of cancer at diagnosis and survival: A
population-based study in Ontario, Canada. Cancer .
2010;116(17):4160-4167. doi:10.1002/cncr.25427
9. WHO. WHO Report on Cancer: Setting Priorities Investing Wisely
and Providing Care for All. ; 2020.
10. McDaniel JT, Nuhu K, Ruiz J, Alorbi G. Social determinants of cancer
incidence and mortality around the world: an ecological study.Glob Health Promot . 2019;26(1):41-49.
doi:10.1177/1757975916686913
11. Yap ML, Oar A, Moraes FY, Ilbawi A. An Evidence-Based National
Cancer Control Program (NCCP) Quality Assessment Checklist. J Glob
Oncol . 2018. doi:10.1200/jgo.18.66800
12. Felix AS, Brinton LA. Cancer progress and priorities: Uterine
cancer. Cancer Epidemiol Biomarkers Prev . 2018;27(9):985-994.
doi:10.1158/1055-9965.EPI-18-0264
13. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB.
Endometrial cancer: Socioeconomic status and racial/ethnic differences
in stage at diagnosis, treatment, and survival. Am J Public
Health . 2004;94(12):2104-2111. doi:10.2105/AJPH.94.12.2104
14. Robinson KM, Christensen KB, Ottesen B, Krasnik A. Socio-demographic
factors, comorbidity and diagnostic delay among women diagnosed with
cervical, endometrial or ovarian cancer. Eur J Cancer Care
(Engl) . 2011;20(5):653-661. doi:10.1111/j.1365-2354.2011.01259.x
15. Doll KM, Winn AN, Goff BA. Untangling the Black-White mortality gap
in endometrial cancer: a cohort simulation. Am J Obstet Gynecol .
2017;216(3):324-325. doi:10.1016/j.ajog.2016.12.023
16. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic
inequalities in stage of cancer diagnosis: Evidence from patients with
female breast,lung, colon, rectal, prostate, renal, bladder, melanoma,
ovarian and endometrial cancer. Ann Oncol . 2013;24(3):843-850.
doi:10.1093/annonc/mds526
17. Svanvik T, Marcickiewicz J, Sundfeldt K, Holmberg E, Strömberg U.
Sociodemographic disparities in stage-specific incidences of endometrial
cancer: a registry-based study in West Sweden, 1995–2016. Acta
Oncol (Madr) . 2019;58(6):845-851. doi:10.1080/0284186X.2019.1581947
18. Strohl AE, Feinglass JM, Shahabi S, Simon MA. Surgical wait time: A
new health indicator in women with endometrial cancer. Gynecol
Oncol . 2016;141(3):511-515. doi:10.1016/j.ygyno.2016.04.014
19. Fader AN, Matsuno Weise R, Sinno AK, et al. Utilization of minimally
invasive surgery in endometrial cancer care: A Quality and cost
disparity. In: Obstetrics and Gynecology . Vol 127. ; 2016:91-100.
doi:10.1097/AOG.0000000000001180
20. Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC.
Disparities in treatment and survival for women with endometrial cancer:
A contemporary national cancer database registry analysis. Gynecol
Oncol . 2016;143(1):98-104. doi:10.1016/j.ygyno.2016.07.107
21. Bregar AJ, Alejandro Rauh-Hain J, Spencer R, et al. Disparities in
receipt of care for high-grade endometrial cancer: A National Cancer
Data Base analysis. Gynecol Oncol . 2017;145(1):114-121.
doi:10.1016/j.ygyno.2017.01.024
22. Foote JR, Gaillard S, Broadwater G, et al. Disparities in the
surgical staging of high-grade endometrial cancer in the United States.Gynecol Oncol Res Pract . 2017;4(1):1-8.
doi:10.1186/s40661-016-0036-3
23. Osborn V, Schwartz D, Lee YC, et al. Patterns of care of IMRT usage
in postoperative management of uterine cancer. Gynecol Oncol .
2017;144(1):130-135. doi:10.1016/j.ygyno.2016.11.017
24. Yap OWS, Matthews RP. Racial and ethnic disparities in cancers of
the uterine corpus. J Natl Med Assoc . 2006;98(12):1930-1933.
25. Randall TC, Armstrong K. Differences in treatment and outcome
between African-American and white women with endometrial cancer.J Clin Oncol . 2003;21(22):4200-4206. doi:10.1200/JCO.2003.01.218
26. Sud S, Holmes J, Eblan M, Chen R, Jones E. Clinical characteristics
associated with racial disparities in endometrial cancer outcomes: A
surveillance, epidemiology and end results analysis. Gynecol
Oncol . 2018;148(2):349-356. doi:10.1016/j.ygyno.2017.12.021
27. Dolly D, Mihai A, Rimel BJ, et al. A delay from diagnosis to
treatment is associated with a decreased overall survival for patients
with endometrial cancer. Front Oncol . 2016;6(FEB):1-5.
doi:10.3389/fonc.2016.00031
28. OECD Interactive Tool: International Comparisons — Peer
Countries, Ontario .; 2019.
https://www.cihi.ca/en/oecd-interactive-tool-peer-countries-on.
29. Kumachev A, Trudeau ME, Chan KKW. Associations among socioeconomic
status, patterns of care and outcomes in breast cancer patients in a
universal health care system: Ontario’s experience. Cancer .
2016;122(6):893-898. doi:10.1002/cncr.29838
30. Kagedan DJ, Abraham L, Goyert N, et al. Beyond the dollar: Influence
of sociodemographic marginalization on surgical resection, adjuvant
therapy, and survival in patients with pancreatic cancer. Cancer .
2016;122(20):3175-3182. doi:10.1002/cncr.30148
31. Anderson LN, Cotterchio M, Boucher BA, Kreiger N. Phytoestrogen
intake from foods, during adolescence and adulthood, and risk of breast
cancer by estrogen and progesterone receptor tumor subgroup among
Ontario women. Int J Cancer . 2013;132(7):1683-1692.
doi:10.1002/ijc.27788
32. Allemani C, Weir HK, Carreira H, et al. Global surveillance of
cancer survival 1995-2009: Analysis of individual data for 25 676 887
patients from 279 population-based registries in 67 countries
(CONCORD-2). Lancet . 2015;385(9972):977-1010.
doi:10.1016/S0140-6736(14)62038-9
33. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index
for use with ICD-9-CM administrative databases. J Clin Epidemiol .
1992;45(6):613-619. doi:10.1016/0895-4356(92)90133-8
34. Soobader MJ, LeClere FB, Hadden W, Maury B. Using aggregate
geographic data to proxy individual socioeconomic status: Does size
matter? Am J Public Health . 2001;91(4):632-636.
doi:10.2105/AJPH.91.4.632
35. Matheson FI, Dunn JR, Smith KLW, Moineddin R, Glazier RH.
Development of the Canadian Marginalization index: A new tool for the
study of inequality. Can J Public Heal . 2012;103(SUPPL.2):3-5.
doi:10.17269/cjph.103.3096
36. McDonald JT, Farnworth M, Liu Z. Cancer and the healthy immigrant
effect: a statistical analysis of cancer diagnosis using a linked
Census-cancer registry administrative database. BMC Public
Health . 2017;17(1):1-14. doi:10.1186/s12889-017-4190-2
37. Cooper N, Quinn MJ, Rachet B, Mitry E, Coleman MP. Survival from
cancer of the uterus in england and wales up to 2001. Br J
Cancer . 2008;99:S65-S67. doi:10.1038/sj.bjc.6604591
38. Stanbury JF, Baade PD, Yu Y, Yu XQ. Cancer survival in New South
Wales, Australia: Socioeconomic disparities remain despite overall
improvements. BMC Cancer . 2016;16(1):48.
doi:10.1186/s12885-016-2065-z
39. Hughes MC, Baker TA, Kim H, Valdes EG. Health behaviors and related
disparities of insured adults with a health care provider in the United
States, 2015–2016. Prev Med (Baltim) . 2019;120(December
2018):42-49. doi:10.1016/j.ypmed.2019.01.004
40. Danos D, Leonardi C, Gilliland A, et al. Increased risk of
hepatocellular carcinoma associated with neighborhood concentrated
disadvantage. Front Oncol . 2018;8(SEP):1-9.
doi:10.3389/fonc.2018.00375
41. Jensen KE, Hannibal CG, Nielsen A, et al. Social inequality and
incidence of and survival from cancer of the female genital organs in a
population-based study in Denmark, 1994-2003. Eur J Cancer .
2008;44(14):2003-2017. doi:10.1016/j.ejca.2008.06.014
42. Wen X, Wen D, Yang Y, Chen Y, Wang G, Shan B. Urban-Rural Disparity
in Helicobacter Pylori Infection–Related Upper Gastrointestinal Cancer
in China and the Decreasing Trend in Parallel with Socioeconomic
Development and Urbanization in an Endemic Area. Ann Glob Heal .
2017;83(3-4):444-462. doi:10.1016/j.aogh.2017.09.004
43. Raglan O, Kalliala I, Markozannes G, et al. Risk factors for
endometrial cancer: An umbrella review of the literature. Int J
Cancer . 2019;145(7):1719-1730. doi:10.1002/ijc.31961
44. Allen NE, Key TJ, Dossus L, et al. Endogenous sex hormones and
endometrial cancer risk in women in the European Prospective
Investigation into Cancer and Nutrition (EPIC). Endocr Relat
Cancer . 2008;15(2):485-497. doi:10.1677/ERC-07-0064
45. Feinberg J, Albright B, Black J, et al. Ten-year comparison study of
type 1 and 2 endometrial cancers: Risk factors and outcomes.Gynecol Obstet Invest . 2019;84(3):290-297. doi:10.1159/000493132
46. Busch EL, Crous-Bou M, Prescott J, et al. Endometrial cancer risk
factors, hormone receptors, and mortality prediction. Cancer
Epidemiol Biomarkers Prev . 2017;26(5):727-735.
doi:10.1158/1055-9965.EPI-16-0821
47. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over
the life course and obesity: Systematic review and meta-analysis. Xiao
G, ed. PLoS One . 2017;12(5):e0177151.
doi:10.1371/journal.pone.0177151
48. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC.
Cardiovascular disease is the leading cause of death among endometrial
cancer patients. Gynecol Oncol . 2012;126(2):176-179.
doi:10.1016/j.ygyno.2012.04.013
49. Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK. Impact of
comorbid conditions on survival in endometrial cancer. Am J Clin
Oncol . 2014;37(2):131-134. doi:10.1097/COC.0b013e318277d5f4